A new AHRQ report found that, although consumers have access to hundreds of smart phone apps for diabetes management, only 11 had been researched, and only five were associated with clinically significant improvements in levels of blood sugar control as measured by hemoglobin A1c (HbA1c) tests. Researchers sought to understand apps’ effectiveness to support self-management of type 1 and type 2 diabetes. A small number of apps were shown to provide benefits beyond A1c control, such as reducing episodes in which blood sugar levels register too high or too low. An article based on the evidence review was published in the Journal of General Internal Medicine. Access the abstract or AHRQ’s press release.
No hay comentarios:
Publicar un comentario